These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27073225)

  • 1. Botulinum Neurotoxin Type-A for the Treatment of Atypical Odontalgia.
    Cuadrado ML; García-Moreno H; Arias JA; Pareja JA
    Pain Med; 2016 Sep; 17(9):1717-21. PubMed ID: 27073225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [OnabotulinumtoxinA in the treatment of atypical odontalgia: description of a clinical case].
    López-Bravo A; Jarauta-Salvador F; Lecina-Monge J; Oliveros-Cid A; Marín-Gracia M; Santos-Lasaosa S
    An Sist Sanit Navar; 2019 Aug; 42(2):209-213. PubMed ID: 31081502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients.
    García-Sáez R; Gutiérrez-Viedma Á; González-García N; Gómez-Mayordomo V; Porta-Etessam J; Cuadrado ML
    J Pain Res; 2018; 11():1583-1588. PubMed ID: 30197533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acupoint injection of onabotulinumtoxin A for migraines.
    Hou M; Xie JF; Kong XP; Zhang Y; Shao YF; Wang C; Ren WT; Cui GF; Xin L; Hou YP
    Toxins (Basel); 2015 Oct; 7(11):4442-54. PubMed ID: 26529014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum injection is useless on fibrotic neuropathic bladders.
    Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
    J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic Effect of Botulinum Toxin A in Myofascial Pain Syndrome Patients Previously Treated with Local Infiltration of Anesthetic and Steroids.
    Cartagena-Sevilla J; García-Fernández MR; Vicente-Villena JP
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):269-275. PubMed ID: 27802066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of local anesthesia on atypical odontalgia--a randomized controlled trial.
    List T; Leijon G; Helkimo M; Öster A; Svensson P
    Pain; 2006 Jun; 122(3):306-314. PubMed ID: 16564621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of botulinum neurotoxin type A for cosmetic applications.
    Carruthers J; Carruthers A
    J Cosmet Laser Ther; 2007 Sep; 9(3):186-92. PubMed ID: 17763029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
    Chajchir I; Modi P; Chajchir A
    Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of at-level spinal cord injury pain with botulinum toxin A.
    Chun A; Levy I; Yang A; Delgado A; Tsai CY; Leung E; Taylor K; Kolakowsky-Hayner S; Huang V; Escalon M; Bryce TN
    Spinal Cord Ser Cases; 2019; 5():77. PubMed ID: 31632735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent orodental pain, atypical odontalgia, and phantom tooth pain: when are they neuropathic disorders?
    Clark GT
    J Calif Dent Assoc; 2006 Aug; 34(8):599-609. PubMed ID: 16967670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A for the treatment of nummular headache: four case studies.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Mar; 48(3):442-7. PubMed ID: 18028377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis.
    Zhang T; Adatia A; Zarin W; Moitri M; Vijenthira A; Chu R; Thabane L; Kean W
    Inflammopharmacology; 2011 Feb; 19(1):21-34. PubMed ID: 21076878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis.
    Elkind AH; O'Carroll P; Blumenfeld A; DeGryse R; Dimitrova R;
    J Pain; 2006 Oct; 7(10):688-96. PubMed ID: 17018329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of previous botulinum neurotoxin treatment on microvascular decompression for hemifacial spasm.
    Wang X; Thirumala PD; Shah A; Gardner P; Habeych M; Crammond DJ; Balzer J; Horowitz M
    Neurosurg Focus; 2013 Mar; 34(3):E3. PubMed ID: 23452316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Rubin M; Dover J; Maas C; Nestor M
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S50-6. PubMed ID: 19945005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.